ARUP's Laboratory Test Directory

0020104: Hepatitis C Virus Antibody (RIBA), Supplemental

Test Mnemonic: HCVAB RIBA
Methodology: Recombinant Immunoblot Assay

Performed: Wed-Sat

Reported: 1-5 days

Specimen Required:  
Collect: One 4 mL SST.

Transport: 1 mL serum at 2-8°C. (Min: 0.5 mL) Submit specimen
in an ARUP Standard Transport Tube.

Submit specimen according to Biological Substance, Category B, shipping guidelines.

Pediatric Collection/Transport: 0.1 mL serum at 2-8°C.

Submit specimen according to Biological Substance, Category B, shipping guidelines.

Remarks: EDTA or citrated plasma is also acceptable.  Separate serum or plasma from cells ASAP.

Stability: After separation from cells: Ambient: Up to 1 week is acceptable, but not preferred; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)

Reference Interval:
Negative

Interpretive Data:
ARUP intends use of this assay for clinical diagnosis.  This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).



Note:
Recombinant immunoblot assay (RIBA) is recommended for specimens with low positive anti-HCV screening results. For high positive anti-HCV screening results, ARUP recommends collecting a new specimen and testing for hepatitis C RNA by PCR or bDNA.

CPT Code(s):
86804